PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCbz
Cbz
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
55 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EpilepsyD004827EFO_0000474G40.92187321
Healthy volunteers/patients718
Bipolar disorderD001714EFO_0000289F30.9617
SeizuresD012640HP_0002069G40.44116
Partial epilepsiesD004828EFO_000426333
NeuralgiaD009437EFO_00094301112
Mood disordersD019964EFO_0004247F30-F3911
AlcoholismD000437EFO_0003829F10.111
ErythromelalgiaD004916I73.8111
DepressionD003863F33.911
Show 3 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.911
Trigeminal neuralgiaD014277EFO_1001219G50.0111
RecurrenceD012008111
Tissue adhesionsD000267111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver diseasesD008107HP_0002910K70-K7711
Liver cirrhosisD008103EFO_0001422K74.011
Alpha 1-antitrypsin deficiencyD019896E88.0111
Reflex epilepsyD020195EFO_100114611
PoisoningD011041EFO_0008546T65.9111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GlioblastomaD005909EFO_000051533
GliomaD005910EFO_000052033
GliosarcomaD01831633
AstrocytomaD001254EFO_000027122
OligodendrogliomaD009837EFO_000063111
InfectionsD007239EFO_000054411
Hiv infectionsD015658EFO_0000764B2011
Acquired immunodeficiency syndromeD000163EFO_0000765B2011
High-intensity focused ultrasound ablationD05708611
Non-small-cell lung carcinomaD00228911
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use